Navigation Links
Bifidogenic Growth Stimulator: A Non-Toxic Way To Treat Ulcerative Colitis

Ulcerative colitis (UC) is an idiopathic inflammatory disorder of the gastrointestinal tract. Although the causes of UC remain incompletely understood, many experimental and clinical observations have suggested involvement of intestinal microflora in its pathogenesis//.

In genetically susceptible individuals, tissue damage can result from failure of normal regulatory constraints on the mucosal immune responsiveness to intestinal bacteria. Therefore, restoring the microbial balance may represent a plausible therapeutic approach in the treatment of UC.

Experimental studies have shown that luminal antigens are involved in chronic intestinal inflammatory disorders. Bifidogenic growth stimulator (BGS) is a prebiotic preparation produced by Propionibacterium freudenreichii isolated from Swiss cheese. Previously BGS was shown to act in the colon as a growth stimulator of Bifidobacteria. A recent study, to be published in Nutrition (Available online 12 October 2005), was designed with the aim to determine the potential therapeutic efficacy and safety of BGS in patients with active UC.

Researchers at the Kurume University, Fukuoka, Japan administered BGS orally (4.5 g daily) for 4 wk to twelve patients with mildly to moderately active ulcerative colitis in an open-label treatment protocol while the baseline anti-inflammatory therapy was continued. The response to treatment was evaluated clinically and endoscopically. Concentrations of short-chain fatty acids and the composition of commensal bacteria, including Bifidobacteria, Enterobacteria and Bacteroides species, were studied in stool samples.

Results from the study indicate that oral BGS resulted in clinical and endoscopic improvements in patients with UC. Treatment with BGS is safe and well tolerated and does not require dietary restrictions.

Thus, oral BGS therapy may represent a non-toxic way to treat ulcerative colitis. However, the authors warn that controlled studies are needed to demonstrate its efficacy in the treatment of this disorder.
'"/>




Related medicine news :

1. Anti-Cancer Drug Restores Normal Cell Growth
2. Low-dose Growth Hormone (GH) with diet and exercise may help weight loss
3. Human Growth Hormone Found To be Dangerous For Human Use
4. Stem Cells Found To Offer Promise For Hair Growth
5. Fish Found To Improve Fetal Growth
6. Growth Patterns In Childhood Could Predict Breast Cancer Later In Life
7. Stopping The Growth Of Viruses
8. Stopping The Growth Of Viruses
9. Turmeric Found To Slow Down Melanoma Growth
10. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
11. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... ... Seminars for Business Journalists , led by the Wharton School’s most prominent ... issues.  This one-day program at the Wharton School’s San Francisco campus will ...
(Date:5/5/2016)... Cambridge, MA (PRWEB) , ... May 05, 2016 ... ... distinctions among workers’ compensation laws in all U.S. states and certain Canadian provinces ... (IAIABC) and the Workers Compensation Research Institute (WCRI). , The report, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Tim Dieter has ... families of greater Dubuque, IA. The current campaign fundraises for Veteran’s Freedom Center ... Donations to Veteran’s Freedom Center may now be made here: http://www.veteransfreedomcenter.com/donate/ . ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic ... Dr. Stong is double board certified and the only facial plastic surgeon in ... hair loss. Non-surgical therapies such as stem cells can be used to provide stabilization ...
(Date:5/5/2016)... ... (PRWEB) May 05, 2016 , ... Talent Tech Labs ... on the eve of National Nurses Week (May 6-12). Currently, HireNurses is ... With their enrollment into the Talent Tech Lab Virtual Incubation program, they will dramatically ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Myeloid Leukemia Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Competitive Landscape Highlights 2016, provides comprehensive insights ... Myeloid Leukemia epidemiology, Acute Myeloid Leukemia market ...
(Date:5/3/2016)... 2016 Global Insulin Needles ... 09 key companies and supported with 272 tables ... study on the current state of the Insulin ... industry including definitions, classifications, applications and industry chain ... for the international market including development history, competitive ...
(Date:5/3/2016)... , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product ... Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology: